All Vaccinology articles – Page 18
-
NewsNegativity about vaccines surged on Twitter after COVID-19 jabs become available
There was a marked increase in negativity about vaccines on Twitter after COVID-19 vaccines became available, while spikes in the number of negative tweets coincided with announcements from healthcare authorities about vaccination.
-
NewsUndocumented Latinx patients got COVID-19 vaccine at same rate as US citizens
For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study has found. These findings surprised researchers, given that COVID-19 disproportionately affected the Latinx ...
-
NewsCervical cancer vaccine very effective in reducing HPV-related disease, but huge variations between countries in coverage
Although evidence is clear that HPV vaccination is reducing cervical cancer incidence and mortality and HPV-related disease, there are high variations in coverage globally, including among high-income countries.
-
NewsLower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to new findings.
-
NewsStudy confirms effectiveness of bivalent COVID-19 vaccine
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a new study.
-
NewsCOVID-19 vaccine effectiveness and fewer common side-effects most important factors in whether adults choose to get vaccinated
Concerns about the common side-effects of COVID-19 vaccines and their effectiveness are key to determining whether adults in Germany and the UK choose to get vaccinated against the virus, according to new research.
-
NewsStudy finds X’s community notes provide accurate, credible answers to vaccine misinformation
A new study finds X’s Community Notes has resulted in hundreds of millions of views of accurate and credible COVID-19 vaccine education, suggesting considerable potential for the correction of misinformation.
-
NewsVaccine candidate could fight antibiotic resistance
Scientists have announced several discoveries that will help the development of a carbohydrate-based vaccine for infections caused by Staphylococcus aureus and its “superbug” relative methicillin-resistant Staphylococcus aureus, or MRSA.
-
NewsEngineers muffle invading pathogens with a ‘molecular mask’
Researchers are developing a hydrogel therapy that acts as a first line of defense against viruses and other biological threats. The peptides that make up this gel prevent viruses such as SARS-CoV-2 from attaching to and entering cells.
-
NewsSafety, immunogenicity and preliminary efficacy of a randomized clinical trial of omicron XBB.1.5-containing bivalent mRNA vaccine
This study reported a very comprehensive evaluation of neutralization against 9 different SARS-CoV-2 variants by three types of variant vaccines of the same delivery system in a head-to-head design.
-
NewsDNA vaccine against zika performs well in tests on mice
A Zika vaccine developed in Brazil and tested on mice has been found to be efficacious, inducing an immune response against the virus and protecting the animals appropriately.
-
NewsImproved oral cholera vaccine achieves WHO PQ
EuBiologics and the International Vaccine Institute (IVI) announced that Euvichol-S, an improved oral cholera vaccine (OCV) developed jointly by EuBiologics and IVI, has achieved World Health Organization prequalification.
-
NewsVaccine breakthrough means no more chasing strains
Scientists have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.
-
NewsChatGPT could help reduce vaccine hesitancy and provide helpful advice on STIs
A pilot study shows the potential for using AI chatbots to assist public health campaigns in reducing vaccine hesitancy as well as providing helpful advice on STIs and access to care.
-
NewsResearchers develop more broadly protective coronavirus vaccine
Researchers have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses.
-
NewsCase report shows mpox breakthrough infection in man who had received both vaccine doses
New research details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a ‘breakthrough’ mpox infection in January 2024.
-
NewsStudy shows Mpox (monkeypox) antibodies wane within a year of vaccination
New research shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination.
-
NewsSignificant decline of neutralising antibodies to monkeypox virus during the first month after vaccination
New research shows that even in men who receive two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.
-
NewsTB vaccine may enable elimination of the disease in cattle by reducing its spread
Vaccination not only reduces the severity of TB in infected cattle, but reduces its spread in dairy herds by 89%, research finds.
-
NewsInsights from patient who cleared hepatitis C could lead to vaccine
By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.